U.S. Home Infusion Therapy Market
Home infusion therapy market in the United States was valued at US$ XX billion globally in 2023 and is projected to reach around US$ XX billion by 2033, with a compound annual growth rate (CAGR) of XX% from 2024 to 2033. Because more companies are starting to offer full-service infusion suites, the home infusion treatment market in the United States is expanding. This expansion is being driven by factors such as increased insurance coverage, which makes it easier for patients to get therapy. Receiving therapy at home helps patients since it enables them to continue with their regular activities while following their treatment plans. Professionals with expertise, such as nurses and pharmacists, guarantee safe and efficient administration outside of conventional medical settings, which propels market expansion even further.

Market Overview 
Need for remote medicine administration is driving the explosive expansion of the home infusion therapy business in the United States. In this approach, patients get infusion therapy from qualified experts, such as nurses and pharmacists, in a variety of locations, including their homes or ambulatory infusion suites. Patients receiving home infusion therapy have the option to carry on with their regular activities, including work and school, while undergoing treatment. Numerous ailments, such as infections, cancer, gastrointestinal issues, and immune system abnormalities, are frequently treated with it. Home infusion service providers provide all-inclusive care, arranging for therapy to be administered to patients at home, on the go, or in dedicated infusion rooms. Depending on the disease, different people require different frequency of treatment; some require daily infusions.
 

Report Highlights     
By Product
 Infusion pumps sector is the largest contributor to the U.S. home infusion therapy industry in terms of market share. Essential machines known as infusion pumps are made to precisely manage the rate at which fluids, such as nutrition or drugs, are infused into a patient's body. They have wide-ranging applications in a variety of clinical settings, such as homes, nursing homes, and hospitals. Since infusion pumps are crucial to the administration of fluids, particularly high-risk drugs, their dependability is crucial to patient safety. The possible repercussions of pump malfunctions highlight how crucial the strong safety features included into these devices are.
. Sophisticated safety measures like alarms and operator alerts are built into a lot of infusion pumps. These features are intended to swiftly inform medical personnel to any anomalies or problems that arise during the infusion procedure. This focus on safety demonstrates the industry's ongoing innovation in infusion pumps, as producers work to improve the dependability and functionality of their goods. The need for sophisticated infusion pump technologies with reliable safety mechanisms is anticipated to endure as healthcare settings change and patient care gets more complex, spurring additional growth and innovation in the market.
Needleless connections market is the fastest-growing segment in the home infusion treatment industry in the United States and is expected to develop at a high rate. The primary goal of needleless connectors, a significant development in healthcare technology, is to reduce the incidence of needlestick injuries among healthcare professionals. These connectors provide a quick and safe way to access infusion lines, allowing for smooth hookups without the use of needles. They significantly contribute to lowering the possibility of unintentional needle punctures and, consequently, the dangers of infection for medical personnel by doing away with the necessity for needles.
It's crucial to remember that although needleless connectors have significantly reduced the number of needlestick injuries, they have also been connected to a number of problems, including catheter lumen occlusion and catheter-related bloodstream infections (CRBSI). These issues highlight the necessity of ongoing innovation and advancement in the design and application of needleless connectors. The market for needleless connections is expected to expand quickly because to the growing focus on infection control and worker safety in the healthcare industry.
 

By Application 
Due to the increasing utilisation of home intravenous anti-infective therapy (HIVAT) as a favored treatment modality, the anti-infective category holds a notable market share in the U.S. home infusion therapy industry. This method has becoming more widely accepted as it has a number of benefits over conventional inpatient care. A multidisciplinary team approach is necessary for the implementation of HIVAT, with a focus on careful patient selection criteria, organized follow-up procedures, and extensive patient education programs. By taking these steps, the inherent hazards of anti-infective medication delivered outside of therapeutic settings are to be minimized.
. HIVAT has numerous advantages that extend beyond the patients' physical health to include their general quality of life. Patients who receive treatment in their homes benefit from increased comfort and convenience, which makes it easier for them to return to regular activities like work or school more quickly. Further improving patient outcomes is the decreased risk of infection and problems connected to intravenous (IV) cannulas.
Growing prevalence of endocrine system disorders is expected to propel the endocrinology section of the U.S. home infusion treatment market toward rapid expansion. Physicians with specific training in this area known as endocrinologists are essential in the diagnosis and treatment of a wide range of endocrine problems, such as obesity, thyroid issues, and diabetes mellitus. The use of intravenous (IV) drip bags loaded with sterile saline solutions that contain personalized combinations of vitamins, minerals, and supplements is one new use in the field of endocrinology.
Bypassing the digestive tract and providing instantaneous circulation to the body's cells, these IV drip treatments provide a direct path into the bloodstream. IV therapies provide clear advantages in terms of potency preservation and absorption efficiency over oral supplements or drugs, which go through digestion and absorption processes. IV drip therapies allow for optimal absorption of nutrients and supplements into the bloodstream, perhaps leading to more effective and quicker therapeutic results.

Market Dynamics
Driver
The Rise of Home Infusion Therapy
Rapidly expanding discipline of home infusion treatment is changing the face of post-acute care by providing patients with an affordable substitute for extended hospital stays. Comprehending the various drug delivery systems makes the transition to home care easier and eventually improves patient outcomes. Home infusion therapy promotes better quality of life and health outcomes by allowing patients who need continuous treatment, are battling infections, or are recovering from surgery to receive care in the comfort of their own homes. The ease and autonomy that come with home infusion, together with developments like infusion backpacks for discrete portability, are important factors driving the expansion of the home infusion treatment industry in the United States.

Restraints 
Challenges in Home IV Care
Health Council of Canada has recommended expanding services and standardizing public reimbursement for critical pharmaceuticals after highlighting major gaps in the availability of home intravenous (IV) treatment nationwide. Funding for various service kinds and access to home IV care fluctuate between Canadian provinces and territories. The successful implementation of home IV therapy is hindered by these differences, which call for the formation of specialized teams, appropriately qualified staff, facilities for the insertion of vascular access devices (VADs), and access to infusion pumps and other necessary instruments. The U.S. home infusion therapy market's potential for expansion is constrained by these disparities and funding and infrastructural gaps.

Opportunities 
Integration of Digital Enablers 
Technological developments have transformed home infusion therapy, increasing its effectiveness and range of use. The ease of getting antibiotic therapy, chemotherapy, pain management, total parenteral nutrition, and blood transfusion therapy in the comfort of one's own home is especially advantageous for cancer patients. A key factor in guaranteeing the secure and smooth integration of home-based IV infusion devices into infusion therapy services is the integration of digital enablers.
. Advancements in technology have revolutionized home infusion therapy, augmenting its efficacy and scope of application. Cancer patients particularly benefit from the simplicity with which they can get blood transfusion therapy, chemotherapy, antibiotic therapy, pain management, and total parenteral nutrition in the comfort of their own homes. The integration of digital enablers is a critical component in ensuring the safe and seamless integration of home-based IV infusion devices into infusion therapy services. 
 

Recent Developments

•    In August 2022, Baxter announced the U.S. FDA clearance of the Novum IQ Syringe Infusion Pump with Dose IQ Safety Software. 
•    In January 2022, One Equity Partners completed an investment in InfuCare Rx, a leading provider of home infusion therapy.

•    In March 2024, Elevance Health announced the completion of the Paragon Healthcare acquisition. 

Key Players in the U.S. Home Infusion Therapy Market
•    Scientific (Pharmaceutical Product Development)
•    Charles River Laboratory
•    ICON plc
•    Wuxi AppTec Parexel International Corp,
•    IQVIA Holdings Inc.
•    LabCorp
•    Thermo Fisher
•    Eli Lilly and Company
•    SGS SA
•    Novo Nordisk A/S
•    Clinipace
•    Syneos Health Inc.
•    Pfizer Inc.

Market Segmentation
Product Outlook 
Infusion pumps
Insulin pumps
Syringe pumps
Elastomeric pumps
Patient Controlled Analgesics (PCA)
Volumetric Pumps Market
Intravenous Sets
IV Cannulas
Needleless Connectors
Application Outlook 
Anti-Infective
Endocrinology
 Diabetes
Others
Hydration Therapy
Athletes
Others
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceuticals
Others

By Geography
North America
U.S.
Canada
Europe
Germany
France
United Kingdom
Rest of Europe
Asia Pacific
China
Japan
India
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
 Rest of Latin America
Middle East & Africa (MEA)
GCC
North Africa
South Africa
Rest of Middle East & Africa